Amphastar Pharmaceuticals Inc [AMPH] stock is trading at $28.99, up 1.97%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AMPH shares have gain 1.86% over the last week, with a monthly amount glided 1.97%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Amphastar Pharmaceuticals Inc [NASDAQ: AMPH] stock has seen the most recent analyst activity on February 04, 2025, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $36 from $66. Previously, Wells Fargo started tracking the stock with Equal Weight rating on November 22, 2024, and set its price target to $55. On March 05, 2024, JP Morgan initiated with a Overweight rating and assigned a price target of $60 on the stock. BofA Securities started tracking the stock assigning a Neutral rating and suggested a price target of $63 on November 17, 2023. In a note dated July 29, 2022, CapitalOne initiated an Overweight rating and provided a target price of $44 on this stock.
Amphastar Pharmaceuticals Inc [AMPH] stock has fluctuated between $25.89 and $53.96 over the past year. Currently, Wall Street analysts expect the stock to reach $32 within the next 12 months. Amphastar Pharmaceuticals Inc [NASDAQ: AMPH] shares were valued at $28.99 at the most recent close of the market. An investor can expect a potential return of 10.38% based on the average AMPH price forecast.
Analyzing the AMPH fundamentals
Amphastar Pharmaceuticals Inc [NASDAQ:AMPH] reported sales of 731.97M for the trailing twelve months, which represents a growth of 4.73%. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at 0.28%, Pretax Profit Margin comes in at 0.26%, and Net Profit Margin reading is 0.22%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.22 and Total Capital is 0.15. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.89.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 28.27 points at the first support level, and at 27.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 29.44, and for the 2nd resistance point, it is at 29.90.
Ratios To Look Out For
For context, Amphastar Pharmaceuticals Inc’s Current Ratio is 3.07. Also, the Quick Ratio is 2.19, while the Cash Ratio stands at 0.87. Considering the valuation of this stock, the price to sales ratio is 1.89, the price to book ratio is 1.89 and price to earnings (TTM) ratio is 9.46.
Transactions by insiders
Recent insider trading involved Petersen Floyd F., Director, that happened on Mar 06 ’25 when 1000.0 shares were sold. CFO, EVP & TREASURER, PETERS WILLIAM J completed a deal on Mar 04 ’25 to sell 4231.0 shares. Meanwhile, Director Petersen Floyd F. bought 1000.0 shares on Mar 06 ’25.
